All lobbying filings

Continental Strategy, LLC

Continental Strategy, LLC filed a Q3 report for Immix Biopharma, Inc. on October 20, 2026, reporting $105,000 in lobbying income.

Lobbying for Immix Biopharma, Inc. · A clinical-stage biopharmaceutical company.

As filed: CONTINENTAL STRATEGY, LLC for IMMIX BIOPHARMA, INC.

All filings by Continental Strategy, LLC · Everything Immix Biopharma, Inc. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$105,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Lobbyists on this filing 2

LUKE NICKLESS

Previously held: Senior Policy Advisor, Appropriations, House Committee on the Budget
TIMOTHY COSTA New on this filing

Previously held: Former Chief of Staff to Dan Meuser

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medical/Disease Research/Clinical Labs

FDA approval standards

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.